Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Mega Genomics Limited ( (HK:6667) ) has shared an announcement.
Mega Genomics Limited has announced that its board of directors will meet on March 31, 2025, to consider and approve the company’s final results for the year ending December 31, 2024. The meeting will also address the recommendation of a final dividend and other business matters, which could impact the company’s financial strategy and shareholder returns.
More about Mega Genomics Limited
Mega Genomics Limited is a company incorporated in the Cayman Islands, operating in the genomics industry. It focuses on providing genomic solutions and services, with a market focus that likely includes healthcare and biotechnology sectors.
YTD Price Performance: -34.88%
Average Trading Volume: 111,123
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$1.63B
Find detailed analytics on 6667 stock on TipRanks’ Stock Analysis page.